Alternative Data for Inogen
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 28 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 175,000 | Sign up | Sign up | Sign up |
| Employee Rating | 46 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2,399 | Sign up | Sign up | Sign up |
| Facebook Followers | 62,661 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,465 | Sign up | Sign up | Sign up |
| X Mentions | 4 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 4,120 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 23 | Sign up | Sign up | Sign up |
| Linkedin Employees | 828 | Sign up | Sign up | Sign up |
About Inogen
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally.
| Price | $6.38 |
| Target Price | Sign up |
| Volume | 293,362 |
| Market Cap | $173M |
| Year Range | $5.59 - $8.95 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Medical Devices |
In the news
Inogen names Jason Richardson CFO, Dominic Hulton CMOMarch 30 - Thefly.com |
|
 |
Inogen Inc (NASDAQ:INGN) Stock Falls on Revenue Miss and Cautious 2026 OutlookFebruary 24 - ChartMill |
Inogen, Inc. (INGN) Q4 2025 Earnings Call TranscriptFebruary 24 - SeekingAlpha |
|
Inogen Sees Q126 Sales in line with 1Q25February 24 - Benzinga |
|
CORRECTION: Inogen Sees FY2026 Sales $366.000M-$373.000M vs $385.250M Est.February 24 - Benzinga |
|
Inogen, Inc. 2025 Q4 - Results - Earnings Call PresentationFebruary 24 - SeekingAlpha |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '26 | 85M | 47M | 38M | -8.3M | -9.3M | -0.140 |
| Q4 '25 | 82M | 41M | 41M | -7.1M | -2.3M | -0.150 |
| Q3 '25 | 92M | 45M | 47M | -5.3M | -220,000 | -0.200 |
| Q2 '25 | 92M | 51M | 41M | -4.2M | 910,000 | -0.150 |
| Q1 '25 | 82M | 46M | 36M | -6.2M | -2.5M | -0.110 |
Insider Transactions View All
| Bourque Michael J. filed to buy 47,646 shares at $8.3. March 4 '25 |
| Smith Kevin Raymond Merrill filed to buy 70,274 shares at $8.6. March 4 '25 |
| Somer Jason filed to sell 4,452 shares at $8.6. May 14 '24 |
| Somer Jason filed to sell 1,161 shares at $28.2. September 6 '22 |
| Glezer Stanislav filed to sell 1,499 shares at $28.2. September 6 '22 |
Similar companies
Read more about Inogen (INGN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Inogen
The Market Cap of Inogen is $173M.
Currently, the price of one share of Inogen stock is $6.38.
The INGN stock price chart above provides a comprehensive visual representation of Inogen's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Inogen shares. Our platform offers an up-to-date INGN stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Inogen (INGN) does not offer dividends to its shareholders. Investors interested in Inogen should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Inogen are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
